Product Information
ONDANSETRON HCL 4 MG/2 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $0.1759 per ML under NDC 65219032302. Its NADAC has been published 69 times since Jun 11, 2025.
FDA first approved this application on Dec 26, 2006. Its Orange Book therapeutic-equivalence code is AP.
Strength
2 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
65219032302
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
ONDANSETRON HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076972FDA Approved
12/26/2006
TE Code
AP
On Market Since
11/18/2009
Pharmacological Classes
Price Statistics
The NADAC for ONDANSETRON HCL 4 MG/2 ML VIAL has been published 69 times since Jun 11, 2025, and over the history we have for it it has declined 14.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1759 per ML |
|---|---|
| All-time high | $0.2128 (Aug 13, 2025) |
| All-time low | $0.1759 (Sep 23, 2026) |
| 52-week high | $0.2112 |
| 52-week low | $0.1759 |
| Median price | $0.1935 |
| Average price | $0.1948 |
| Largest weekly change | +2.4% (Jul 23, 2025) |
| Weeks tracked | 69 |
| Tracking since | Jun 11, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ONDANSETRON HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-3 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ONDANSETRON HCL 4 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ONDANSETRON HCL 4 MG/2 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $0.1759 per ML (NDC 65219032302), effective Sep 30, 2026.
How has the price of ONDANSETRON HCL 4 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for ONDANSETRON HCL 4 MG/2 ML VIAL has declined 14.1%. It has been tracked across 69 weekly CMS publications since Jun 11, 2025.
What are the highest and lowest recorded NADAC prices for ONDANSETRON HCL 4 MG/2 ML VIAL?
Since Jun 11, 2025, the NADAC for ONDANSETRON HCL 4 MG/2 ML VIAL has ranged from a low of $0.1759 (Sep 23, 2026) to a high of $0.2128 (Aug 13, 2025), with a median of $0.1935 per ML.
Are there cheaper alternatives to ONDANSETRON HCL 4 MG/2 ML VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ONDANSETRON 40 MG/20 ML VIAL, is $0.1730 per ML — about 2% below ONDANSETRON HCL 4 MG/2 ML VIAL.
Who manufactures ONDANSETRON HCL 4 MG/2 ML VIAL?
ONDANSETRON HCL 4 MG/2 ML VIAL (NDC 65219032302) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.